Hiv monoclonal antibody

C - Chemistry – Metallurgy – 12 – P

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12P 21/08 (2006.01)

Patent

CA 2046016

-1- A monoclonal antibody is described capable of binding to a glycoprotein antigen having a molecular weight of about 12 x 10 4 daltons (gp120) present in the envelope of human immunodeficiency virus (HIV) and capable of substantially neutralizing the HIV, or fragments thereof. It has the characteristics of immunoglobulin class IgG, k, being capable of binding to glycoprotein antigen having a molecular weight of 12 x 10 4 daltons (gp120) of HTLV-III MN, being capable of recognizing at least one epitope which is present in the region of the amino acid sequence 303 to 325 of gp120 of HTLV-III MN, being capable of binding to the surface of HTLV-III MN viral particles and thereby inhibiting the infection of the viral particles to CD4-positive cells, and being capable of binding to the surface of cells infected with HTLV-III MN and thereby inhibiting the syncytium formation induced by interaction between the infected cells and uninfected cells. The monoclonal antibody is useful for the prophylaxis, treatment and diagnosis of AIDS.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hiv monoclonal antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hiv monoclonal antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hiv monoclonal antibody will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1620185

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.